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Introduction {#sec1}
============

As a key factor for S phase entry, Cyclin E (CycE) is crucial for both mitotic and endocycling cells ([@bib5]; [@bib12]; [@bib16]). Previous studies have shown that transcription factor E2f, a heterodimer of E2f1 and Dp, plays an important role in *cycE* expression in normal cell cycle and endocycle ([@bib3]; [@bib7]; [@bib27]; [@bib31]). However, *Drosophila e2f1* null mutant can survive to the third-instar larval stage and residual S phase occurs in the mutant cells ([@bib6]; [@bib21]), suggesting an involvement of another transcription factor in S phase entry.

One candidate for such factor is Apt. *Drosophila* Apt (also termed Trachea defective, Tdf) is a DNA-binding transcription factor that is involved in the development of multiple organs and tissues, such as tracheae, head, heart, ovary, stem cell, nervous system, and imaginal discs ([@bib9]; [@bib10]; [@bib15]; [@bib17], [@bib18]; [@bib19]; [@bib22]; [@bib23]; [@bib24]; [@bib28]). We have found that Apt directly regulates the expression of *cycE* during the development of imaginal discs ([@bib18]; [@bib28]). Therefore, Apt might participate in the expression of *cycE* in other tissues also. Besides, Apt can suppress tumor metastasis, and the human homolog of Apt, FSBP, is a cancer-related factor ([@bib14]; [@bib30]).

Although CycE is crucial for S phase entry, it should decrease subsequently for progression of the cell cycle. Rbf1 is a key player in the decline of CycE expression ([@bib2]; [@bib13]; [@bib27]; [@bib29]). During S phase entry, Rbf1 is inactivated by phosphorylation with Cyclin-dependent kinase 2 (Cdk2) but becomes active by de-phosphorylation after initiation of S phase ([@bib4]; [@bib8]; [@bib27]). The activated Rbf1 binds to E2f1 and also forms another complex containing E2f2 and Dp to repress E2f1-target genes including *cycE* and many other genes ([@bib2]; [@bib13]; [@bib27]; [@bib29]). Retinoblastoma protein (Rb), a mammalian counterpart of Rbf1, promotes chromatin compaction for transcriptional silencing by interaction with chromatin regulators such as histone deacetylases and histone methyltransferases ([@bib1]; [@bib20]; [@bib25]). Therefore, Rbf1 is also expected to participate in chromatin compaction for silencing.

Here we provide evidence that both *Drosophila* Apt and mouse FSBP play important roles in the induction of CycE and up-regulation of Rbf1 for proper chromatin compaction. Mechanistically, we showed that Apt and E2f1 mutually activate the expression of each other to induce *cycE* for S phase entry in the salivary gland. Furthermore, we observed that the binding motifs of Apt and E2f are clustered in the first intron of *cycE*. Based on the results of chromatin immunoprecipitation (ChIP) and transgenic reporter assays, we found direct contribution of the Apt-binding sites and the E2f1-binding sites to the *cycE* transcription in the salivary gland. Moreover, we also found that Apt up-regulates Rbf1 to direct proper chromatin compaction for transcriptional silencing. Finally, we demonstrated evolutionary conservation of these mechanisms in mammalian cells.

Results {#sec2}
=======

Apt and E2f1 Activate Expression of Each Other {#sec2.1}
----------------------------------------------

To investigate the function of Apt in endoreplication of the salivary gland, we first compared the expression of Apt and E2f1 proteins by immunostaining ([Figure 1](#fig1){ref-type="fig"}A). Endocycle in the salivary gland proceeds asynchronously, and hence each cell resides in various phases of endocycle. E2f1 peaks at S phase entry and declines after initiation of S phase ([@bib31]). According to the oscillation of E2f1 during endocycle, some cells expressed E2f1 strongly, whereas other cells expressed weakly. Intriguingly, we noticed that the expression of Apt exhibits a similar pattern as that of E2f1. The observed tight correlation between the levels of Apt and E2f1 proteins suggests almost-synchronous oscillation of Apt and E2f1 during endocycle.Figure 1Apt and E2f1 Up-regulate Each Other in the Salivary Gland(A) Expression of Apt and E2f1 at 72--84 h after egg laying (AEL). Each picture is the same single focal plane image of the salivary gland obtained with a confocal microscope. n = 16 with all samples showing the represented phenotype. Scale bar, 20 μm. The graph shows the correlation between Apt and E2f1 protein levels in each cell. n = 177. R^2^ (coefficient of determination) = 0.89.(B) RT-qPCR assays for expression of *e2f1*, *apt,* and *cycE* mRNAs. The glands were prepared from early third-instar larvae. Data were average ± SD relative to the *dpp* \> *GFP* mRNA level. *dpp* \> *GFP* samples were normalized to 1. ∗∗∗p \< 0.001 (Student\'s t test).(C) Transgenic reporter assays for *apt* transcription. The reporter *AptPlacZ* (*apt* promoter region with wild-type E2f1-binding motifs) showed an expression pattern similar to the endogenous E2f1 expression. n = 8 with all samples showing the represented phenotype. *AptMPlacZ* (base substitutions in the E2f1-binding motifs in the *apt* promoter region) showed significantly decreased LacZ expression. n = 5 with all samples showing the represented phenotype. Scale bars, 20 μm.(D) RT-qPCR assays for *lacZ* mRNA levels from AptPlacZ or AptMPlacZ. Data were average ± SD relative to the mRNA level of AptPlacZ. ∗∗∗p \< 0.001 (Student\'s t test).See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

As Apt and E2f1 are transcription factors, the strong correlation between the levels of Apt and E2f1 could be due to the interdependence of the *apt* and *e2f1* expression. To test the possibility, we analyzed mRNA levels of *apt* and *e2f1* in the salivary gland by RT-qPCR. To compare the mRNA levels among samples with different genome dosages, each mRNA level was normalized to that of β-tubulin mRNA. RNAi knockdown of *e2f1* using a *dpp*-*GAL4* driver ([Figure S1](#mmc1){ref-type="supplementary-material"}A) decreased the expression of *apt*, and vice versa ([Figure 1](#fig1){ref-type="fig"}B). Furthermore, the expression of Apt and E2f1 proteins were dependent on each other ([Figure S1](#mmc1){ref-type="supplementary-material"}B). These data demonstrate mutual activation of *apt* and *e2f1*. The positive feedback between *apt* and *e2f1* would support their rapid and robust transaction. To examine whether these activations are direct or not, we searched for E2f1- and Apt-binding motifs in the *apt* or *e2f1* promoter. E2f1-binding sites were found in the *apt* promoter region, suggesting that E2f1 might directly activate *apt* transcription. We used the 1.5-kb promoter region containing the E2f1-binding sites ([Figure S2](#mmc1){ref-type="supplementary-material"}) to verify this possibility through transgenic reporter assays. As we expected, wild-type reporter gene was expressed in the salivary gland ([Figure 1](#fig1){ref-type="fig"}C), whereas the expression level of the reporter gene significantly decreased in the E2f1-binding site mutant line ([Figures 1](#fig1){ref-type="fig"}C and 1D). These results demonstrate that E2f1 can directly activate *apt* transcription in the salivary gland. Because the Apt-binding site was not found in the *e2f1* promoter region, the *apt*-mediated activation of *e2f1* might be indirect.

Both Apt and E2f1 Are Required for CycE Expression and Endoreplication {#sec2.2}
----------------------------------------------------------------------

Considering the tight correlation between the expression of Apt and E2f1, it is most likely that Apt is involved in endocycle together with E2f1. To test the possibility, we induced *apt* null mutant clones in embryonic salivary glands where cells still undergo mitosis and observed the glands at the third-instar larval stage after many rounds of endoreplication in control cells. Compared with control cells, *apt*-knockout cells showed obvious decrease in DAPI fluorescence ([Figures 2](#fig2){ref-type="fig"}A and 2B). The decreased DAPI fluorescence indicates the role for Apt in endoreplication. In addition to the decreased DAPI staining, loose chromatin appearance was observed in *apt*-mutant clone cells ([Figure 2](#fig2){ref-type="fig"}A). We will refer to the phenotype in the later section.Figure 2Apt Is Required for Endoreplication and CycE Expression in the Salivary Gland(A) An *apt*-mutant clone (marked by white dotted lines) was stained with DAPI. n = 12 with all samples showing the represented phenotype. Scale bar, 20 μm.(B) Quantification of DAPI fluorescence from *apt*-mutant clone cells and neighboring control cells. Data were presented as mean ± SD. n = 4 cells for *apt*-mutant clones and 10 cells for control. ∗∗∗p \< 0.001 versus the control (Student\'s t test).(C) Immunofluorescence staining with anti-CycE antibody and DAPI in *apt*-mutant clones. Arrows show reduced expression of CycE in *apt*-mutant clones. n = 11 with all samples showing the represented phenotype. Scale bar, 20 μm.(D) *e2f1*-knockout cells (marked by red arrowheads) showed lower ploidy. n = 7 with all samples showing the represented phenotype. Scale bar, 20 μm.(E) An *apt*- and *e2f1*-double knockout cell (marked by yellow arrowheads) showed almost no endoreplication. n = 4 with all samples showing the represented phenotype. Scale bar, 20 μm.(E′) Close-up image around the yellow arrowhead in (E). Scale bar, 20 μm.(F) CycE was decreased but still detectable in an *e2f1*-mutant cell (marked by red arrowheads). n = 4 with all samples showing the represented phenotype. Scale bar, 20 μm.(G) *apt*- and *e2f1*-double mutant cell (marked by yellow arrowheads) abolished CycE expression. n = 3 with all samples showing the represented phenotype. Scale bar, 20 μm.(H) Quantification of DAPI fluorescence in *e2f1*-mutant clone cells, *apt*-*e2f1*-double mutant clone cells, and neighboring control cells. Data were presented as mean ± SD. n = 4 cells for control, 3 cells for *e2f1*-mutant clone, and 3 cells for *apt*-*e2f1*-double mutant clone. ∗∗∗p \< 0.001 versus the control (Student\'s t test). See also [Table S4](#mmc1){ref-type="supplementary-material"}.

In agreement with the previous studies ([@bib3]; [@bib7]; [@bib27]; [@bib31]), knockdown of *e2f1* decreased the expression of *cycE* in the salivary gland ([Figure 1](#fig1){ref-type="fig"}B). Furthermore, knockdown of *apt* also reduced the expression of *cycE*. Having established that both E2f1 and Apt are *cycE* activators, we compared the DNA content and CycE protein level among control cells, *apt*-knockout cells, *e2f1*-knockout cells, and *apt*- and *e2f1*-double knockout cells. The DNA content decreased clearly in *apt*- or *e2f1*-knockout clone cells ([Figures 2](#fig2){ref-type="fig"}A, 2B, 2D and 2H). Double knockout of *apt* and *e2f1* completely blocked endoreplication ([Figures 2](#fig2){ref-type="fig"}E, 2E′ and 2H). Knockout of either *apt* or *e2f1* significantly decreased the CycE expression, but residual CycE protein was still detectable ([Figures 2](#fig2){ref-type="fig"}C and 2F). Upon double knockout of *apt* and *e2f1*, the expression level of CycE reduced below the detection limit ([Figure 2](#fig2){ref-type="fig"}G). These data collectively demonstrate that both Apt and E2f1 are required for proper CycE expression and endoreplication in the salivary gland.

Apt and E2f1 Can Directly Activate c*ycE* Transcription {#sec2.3}
-------------------------------------------------------

As Apt and E2f1 activate the expression of each other and both Apt and E2f1 are required for the CycE expression, effect of *e2f1* null mutation on the CycE expression is a combination of a direct effect due to the absence of E2f1 and an indirect effect due to the reduced Apt level. To address the direct contribution of Apt or E2f1 to *cycE* transcription, we focused on *cis*-regulatory elements of *cycE*. Expression of *cycE* is regulated by complex tissue-specific *cis*-elements ([@bib11]). Although *cis*-elements for the expression in the salivary gland have not been reported, we found a clustering of two adjacent E2f1-binding motifs and four Apt-binding motifs in the first intron of *cycE* ([Figure 3](#fig3){ref-type="fig"}A). To test whether Apt or E2f1 binds to these motifs, we carried out ChIP experiments using Apt or E2f1 antibodies. The ChIP data clearly showed that Apt and E2f1 bind to the corresponding motifs ([Figures 3](#fig3){ref-type="fig"}B and 3C). Consistently, RNAi knockdown of *apt* prominently reduced the occupancies of Apt on the Apt motifs ([Figure 3](#fig3){ref-type="fig"}B). We then assessed the functional activities of these sites by transgenic reporter assays ([Figures 3](#fig3){ref-type="fig"}D and [S3](#mmc1){ref-type="supplementary-material"}A). Control reporter carrying the 3-kb wild-type *cycE* region (*cycEPlacZ*) expressed LacZ in the salivary gland. Compared with the control, the LacZ expression decreased but was still detectable in E2f1-binding site mutation line (*E2f1BSMPlacZ*). Simultaneous disruption of the E2f1- and Apt-binding sites (*E2f1BSM* + *AptBSMPlacZ*) virtually abolished the reporter gene expression. Furthermore, the LacZ expression in *E2f1BSMPlacZ* reduced significantly upon RNAi knockdown of *apt* compared with non-RNAi control ([Figure S3](#mmc1){ref-type="supplementary-material"}B). These data demonstrate that Apt and E2f1 can directly activate the *cycE* transcription. These data also indicate that both the Apt- and E2f1-binding sites are required for the normal level of *cycE* transcription.Figure 3Both Apt- and E2f1-Binding Sites Are Required for Normal Level of *cycE* Transcription(A) Clustering of Apt- and E2f1-binding motifs in the first intron of *cycE*. Apt-binding motifs and E2f1-binding motifs are indicated in red and blue, respectively.(B and C) ChIP assays revealed occupancy of Apt (B) or E2f1 (C) at each binding motif. ChIP-qPCR was performed using antibodies against Apt (B) or E2f1 (C). Control regions of the anti-Apt antibody ChIP were set around 1.2 kb upstream of the Apt motif 1 (Ctr-1) and around 1.2 kb downstream of the Apt motif 4 (Ctr-2). Control regions of the anti-E2f1 antibody ChIP were set around 1.2 kb upstream of the E2f1 motif 1 (Ctr-1) and around 1.4 kb downstream of the E2f1 motif 2 (Ctr-2). Data were presented as mean ± SD. n = three biological replicates. ∗∗∗p \< 0.001 (Student\'s t test) between *ptc-GAL4* and control IgG or between *apt*RNAi and control *ptc-GAL4* in (B) and versus control IgG in (C).(D) Reporter assays for contribution of Apt- and E2f1-binding motifs to *cycE* transcription. The left panel shows strategy of the transgenic reporter assays. Middle panel: The wild-type reporter (*cycEPlacZ*) displayed clear LacZ expression. n = 16 with all samples showing the represented phenotype. The E2f1-binding motif\'s mutant reporter (*E2f1BSMPlacZ*) exhibited reduced LacZ expression. n = 11 with all samples showing the represented phenotype. The reporter of Apt- and E2f1-binding motif\'s mutant (*E2f1BSM* + *AptBSMPlacZ*) almost abolished the LacZ expression. n = 8 with all samples showing the represented phenotype. Scale bars, 100 μm. Right panel: Quantification of the LacZ expression.Data were mean ± SD relative to the level of *cycEPlacZ*. n = 23 for *cycEPlacZ*, 20 for *E2f1BSMPlacZ,* and 29 for *E2f1BSM* + *AptBSMPlacZ*. ∗∗∗p \< 0.001 (Student\'s t test). See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}.

The 3-kb regulatory element of *cycE* (termed I element here) is different from the 4-kb region (termed U element) that governs the *cycE* expression in the eye and wing discs ([@bib18]; [@bib28]). The I element is within the first intron, whereas the U element is immediately upstream of the start site of the *cycE* transcript A ([@bib26]) ([Figure S4](#mmc1){ref-type="supplementary-material"}A). E2f1-binding sites are present in the I element but not in the U element. To test the specificity of the cis-regulatory region, we checked the reporter activity of the I element in the eye disc. The I element failed to reproduce the complete expression pattern of CycE in the eye disc ([Figure S4](#mmc1){ref-type="supplementary-material"}B). These results further support the tissue-specific regulation of *cycE* ([@bib11]).

Apt Up-regulates Rbf1 and Directs Proper Chromatin Compaction {#sec2.4}
-------------------------------------------------------------

*e2f1* mutant cells induced in the salivary gland displayed small nuclei with low DNA content ([Figure 2](#fig2){ref-type="fig"}D). This is exactly expected from the reduced endoreplication. By contrast, nuclei of *apt* mutant cells were abnormal. Despite the reduced level of endoreplication, the size of nuclei in the *apt* mutant clone cells was comparable to that of control cells ([Figure 2](#fig2){ref-type="fig"}A). The ratio of nuclear size to DNA content was \~6.5 times higher in *apt*-mutant cells than that in control cells ([Figure 4](#fig4){ref-type="fig"}A). A higher-magnification image of *apt* mutant nuclei exhibited intra-chromosomal chromatin de-compaction and large inter-chromosomal spaces compared with control nuclei ([Figure S5](#mmc1){ref-type="supplementary-material"}). As the loose chromatin is associated with increased transcription activity, loss of *apt* function would induce de-repression of multiple genes. Indeed, *apt*-knockout cells exhibited many signals of transcribing RNA polymerase II, under the conditions where the signals were barely detectable in control cells ([Figure 4](#fig4){ref-type="fig"}B). Then, what is a global repressor that governs the silencing of many genes in the downstream of Apt? One candidate is Rbf1, because it forms a complex with E2f1 and another complex including E2f2 and Dp to repress E2f-target genes and many other genes ([@bib2]; [@bib13]; [@bib27]; [@bib29]). Consistent with this idea, we observed large nuclei with de-compacted chromatin upon RNAi knockdown of *rbf1* ([Figure 4](#fig4){ref-type="fig"}C). Therefore, it is possible that Apt up-regulates *rbf1,* and hence the *apt* mutant cells exhibit large nuclei with de-compacted chromatin. To test the possibility, we analyzed the expression of *rbf1* in the salivary gland by RT-qPCR. As shown in [Figure 4](#fig4){ref-type="fig"}D, we observed a significant reduction in the expression of *rbf1* and *e2f2* upon RNAi knockdown of *apt* leaving the *dp* expression unchanged. We also examined the expression of Rbf1 protein in *apt*-knockout or *apt*-overexpressing cells. Compared with control cells, *apt*-mutant clone cells showed decreased expression of Rbf1 protein, whereas *apt*-overexpressing cells exhibited highly compact chromatin with increased Rbf1 protein levels ([Figures 4](#fig4){ref-type="fig"}E and 4F). Consistently, we observed de-repression of Rbf1-target genes, such as *CG4679*, *gigas*, *diap3,* and *Ipp* upon knockdown of *apt* ([Figure 4](#fig4){ref-type="fig"}D). Importantly, overexpression of Rbf1 suppressed chromatin de-compaction upon RNAi knockdown of *apt* ([Figure 4](#fig4){ref-type="fig"}G). Based on these results, we reasoned that the nuclear defects in the *apt*-knockout cells are due to release from Rbf1-mediated chromatin compaction and de-repression of many Rbf1-target genes.Figure 4Apt Regulates Chromatin Compaction through *rbf1* in the Salivary Gland(A) The ratio of nuclear size to DNA content in *apt*-mutant clone cells, *e2f1*-mutant clone cells, or control cells. Data were presented as mean ± SD. n = 10 for control, 4 for *apt*-mutant clone, and 3 for *e2f1*-mutant clone. ∗∗∗p \< 0.001 versus the control (Student\'s t test).(B) Immunostaining of control or *apt*-mutant clone cells with the antibody against transcribing RNA polymerase II (H14). An *apt*-mutant clone cell (marked by yellow dotted line) showed prominent signals of transcribing RNA polymerase II compared with control cells. n = 3 with all samples showing the represented phenotype. Scale bar, 20 μm.(C) *ptc-GAL4*-driven RNAi knockdown of *rbf1* induces de-compaction of chromatin. Compared with control cells, *rbf1*-knockdown cells exhibited larger nuclei with de-compacted chromatin. n = 10 with all samples showing the represented phenotype. Scale bars, 20 μm. Graph shows the ratio of nuclear size to DNA content. Data were mean ± SD relative to control. n = 100 for control and 100 for *rbf1* RNAi. The control samples were normalized to 1. ∗∗∗p \< 0.001 (Student\'s t test).(D) RT-qPCR assays for the expression of *dp*, *rbf*, *e2f2,* and Rbf1-target genes (*CG4679*, *gigas*, *diap3*, *Ipp*) in *dpp* \> *GFP* control and *dpp* \> GAL4-driven *apt*-knockdown salivary glands. Data were average ±SD relative to the *dpp* \> *GFP* mRNA level. *dpp* \> *GFP* samples were normalized to 1. ∗∗p \< 0.01, ∗∗∗p \< 0.001 (Student\'s t test).(E) The expression of Rbf1 in *apt*-mutant clone cells. Arrows indicate the decreased expression of Rbf1 in the clone. n = 4 with all samples showing the represented phenotype. Scale bar, 20μm.(F) Up-regulation of Rbf1 in *apt*-overexpression cells. Yellow arrowheads indicate *y*^*+*^-flipped out cells expressing *actin-GAL4* that drives overexpression of *apt*. n = 4 with all samples showing the represented phenotype. Scale bar, 20 μm. fb, fat body.(G and H) (G) Chromatin de-compaction upon *ptc*-*Gal4*-driven RNAi of *apt* was suppressed by simultaneous overexpression of Rbf1. Upper panels are low-magnification images. Lower panels show higher-magnification images of the nuclei. n = 10 with all samples showing the represented phenotype. Scale bars, 20 μm. Graph shows the ratio of nuclear size to DNA content. Data were mean ± SD relative to control. n = 100 for control, 100 for *apt* RNAi, and 100 for *apt* RNAi + Rbf1 overexpression. The control samples were normalized to 1. ∗∗∗p \< 0.001 (Student\'s *t*-test). (H) ChIP assays showed occupancy of Apt on its binding motif at 156 nucleotides upstream of the transcription start site of *rbf1*. A control region was set around 500 nucleotides downstream of the Apt-binding motif. Data were presented as mean ± SD. n = three biological replicates. ∗∗∗p \< 0.001 versus the control (Student\'s t test). See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

There exists a single Apt-binding motif at 156 nucleotides upstream of the transcription start site of *rbf1*. ChIP assays showed occupancy of Apt on the motif ([Figure 4](#fig4){ref-type="fig"}H). These data suggest that *rbf1* is a direct target of Apt.

Apt Up-regulates Rbf1 Also in Mitotic Cycling Cells {#sec2.5}
---------------------------------------------------

So far, we demonstrate the roles for Apt in the induction of CycE and chromatin compaction for silencing in endocycling salivary gland cells. Then, how is the situation in mitotic cycling cells? We have shown that Apt activates the *cycE* expression for S phase entry in imaginal disc cells undergoing mitotic cycles ([@bib18]; [@bib28]). This led us to examine whether Apt up-regulates Rbf1 also in the wing disc. Strong knockdown and overexpression of *apt* induced cell migration and apoptosis, respectively, in the wing disc, which hampered inspection of the nuclear defects. Therefore, we employed mild knockdown or overexpression of *apt* that was triggered by heat shock-induced flipping out of *y*^*+*^ from *actin \> y*^*+*^\>*GAL4*. RNAi knockdown of *apt* reduced the Rbf1 expression ([Figure 5](#fig5){ref-type="fig"}A) and slightly increased the nuclear size/DNA ratio in wing disc cells ([Figure 5](#fig5){ref-type="fig"}B). Conversely, overexpression of Apt enhanced the Rbf1 expression ([Figure 5](#fig5){ref-type="fig"}C) and reduced the nuclear size/DNA ratio ([Figure 5](#fig5){ref-type="fig"}D). These results indicate that Apt up-regulates Rbf1 to direct proper chromatin compaction in wing disc cells also. Collectively, these data suggest that Apt-mediated CycE induction and chromatin compaction are general mechanisms common to both mitotic cycling and endocycling cells.Figure 5Apt Regulates the Expression of Rbf1 and Chromatin Compaction in the Wing Disc(A) Immunostaining of a wing disc harboring *apt*-knockdown clones with anti-Rbf1 antibody (red). GFP (green) represents the region of *y*^*+*^-flipped out *apt*-knockdown cells. n = 20 with all samples showing the represented phenotype. Lower panels are close-up images around the *apt*-knockdown clone. Scale bars, 20 μm.(B) The wing disc nuclei of control cells (without GFP) and *apt*-knockdown cells (with GFP) were stained with DAPI. n = 3 with all samples showing the represented phenotype. Red dotted line indicates the boundary between control cells and *apt*-knockdown cells. Scale bar, 20 μm. Graph shows the ratio of nuclear size to DNA content in the control or *apt*-RNAi cells. Data were mean ± SD relative to control. n = 55 for control and 32 for *apt*-RNAi. The control samples were normalized to 1. ∗∗p \< 0.01 (Student\'s t test).(C) Immunostaining of a wing disc harboring *apt*-overexpression cells with anti-Rbf1 antibody (red). GFP (green) implies the *y*^*+*^-flipped out *apt*-overexpressing region. n = 25 with all samples showing the represented phenotype. Scale bar, 20 μm.(D) The wing disc nuclei of control cells (without GFP) and *apt*-overexpression cells (with GFP) were stained with DAPI. n = 3 with all samples showing the represented phenotype. Red dotted line indicates the boundary between control cells and *apt*-overexpression cells. Scale bar, 20 μm. Graph shows the ratio of nuclear size to DNA content. Data were mean ± SD relative to control. n = 40 for control and 52 for *apt*-overexpression. The control samples were normalized to 1. ∗∗∗p \< 0.001 (Student\'s t test).

Mutual Activation of *FSBP* and *E2f1*, and FSBP-Mediated Chromatin Compaction in Mammalian Cells {#sec2.6}
-------------------------------------------------------------------------------------------------

As Apt, E2f1, and Rbf1 are evolutionarily conserved transcription factors, the aforementioned mechanisms could be also conserved in mammalian cells. To test the possibility, we focused on the mammalian homologs of these factors, FSBP, E2f1, and Rb. In mouse NIH3T3 cells, RNAi knockdown of *FSBP* significantly decreased the expression of *E2f1* and *CycE* homologs (*CCNE1* and *CCNE2*) ([Figure 6](#fig6){ref-type="fig"}A). Upon *E2f1* knockdown, the expression of *FSBP*, *CCNE1,* and *CCNE2* were attenuated ([Figure 6](#fig6){ref-type="fig"}A). These data indicate mutual activation between *FSBP* and *E2f1* and requirement of *FSBP* and *E2f1* for the expression of *CCNEs*. In addition, knockdown of *FSBP* reduced the expression of *Rb1*, whereas overexpression of *FSBP* increased the *Rb1* expression ([Figure 6](#fig6){ref-type="fig"}B). Consistently, the target genes of Rb (*CDC6* and *DHFR*) also showed up- and down-regulation in *FSBP*-knockdown and *FSBP*-overexpressing cells, respectively ([Figure 6](#fig6){ref-type="fig"}B). These data indicate FSBP-mediated up-regulation of Rb. Furthermore, each *FSBP*-knockdown cell exhibited a large nucleus with less compact chromatin and a lower Rb protein level than the control cell did ([Figures 6](#fig6){ref-type="fig"}C--6E). Taken together, these results demonstrate Apt- and FSBP-mediated conserved mechanisms for CycE induction and chromatin compaction.Figure 6Mutual Activation between *FSBP* and *E2f1*, and FSBP-Mediated Chromatin Compaction in Mouse NIH3T3 Cells(A) RT-qPCR assays for relative mRNA levels of *FSBP*, *E2f1*, *CCNE1,* and *CCNE2* in *FSBP*-knockdown cells or *E2f1*-knockdown cells. Data were mean ± SD relative to *Mock*. ∗p \< 0.05, ∗∗p \< 0.01 (Student\'s t test).(B) Relative mRNA levels of *FSBP*, *Rb1*, *CDC6,* and *DHFR* from *FSBP*-knockdown cells or ectopic FSBP-expressing cells. Data were mean ± SD relative to *Mock*. ∗p \< 0.05, ∗∗p \< 0.01, ∗∗∗p \< 0.001 (Student\'s t test).(C) Control and *FSBP*-knockdown cells were stained with DAPI (blue) and anti-FSBP antibody (green). n = 81 cells for control and 25 cells for *FSBP* knockdown with all samples showing the represented phenotype. Scale bar, 20 μm.(D) Control and *FSBP*-knockdown cells were stained with DAPI (blue) and anti-Rb1 antibody (red). n = 85 cells for control and 26 cells for *FSBP* knockdown with all samples showing the represented phenotype. Scale bar, 20 μm.(E) Quantification of the nuclear size. Data were mean ± SD relative to *Mock*. n = 16 for control and 6 for FSBP RNAi. ∗∗∗p \< 0.001 (Student\'s t test).

Discussion {#sec3}
==========

This study revealed Apt-mediated up-regulation of two key players in the cell cycle, CycE and Rbf1. What is the significance of this finding? The positive feedback between *apt* and *e2f1* ensures rapid and robust induction of CycE at S phase entry. Apt also up-regulates Rbf1, but Rbf1 is inactivated through phosphorylation with Cdk2. After initiation of S phase, Rbf1 becomes active through de-phosphorylation and represses *cycE* ([@bib4]; [@bib8]; [@bib27]). Together with Crl4^Cdt2^-mediated degradation of E2f1 ([@bib31]), this leads to a rapid decline of CycE. Therefore, Apt governs both induction and subsequent repression of *cycE* with the aid of the periodic phosphorylation and de-phosphorylation of Rbf1.

E2f, a heterodimer of E2f1 and Dp, has been studied for many years, and it is a key regulator of CycE expression for S phase entry ([@bib7]). However, residual S phase takes place in a null mutant of *Drosophila e2f1* or *dp* ([@bib6]; [@bib21]). Here, we solved the discrepancy: another factor Apt also participates in the activation of *cycE*. Until this study, contribution of "another factor" if any was thought to be rather trivial compared with that of E2f, because *e2f1* or *dp* mutation severely reduced the CycE expression. Our study revealed that the notion is not correct. As Apt and E2f1 up-regulate each other and both Apt and E2f1 are required for the *cycE* expression, disruption of *e2f1* or *dp* function leads to depletion of both E2f and Apt, which in turn causes a severe defect in *cycE* expression. This masked the contribution of "another factor" Apt. Actually, transgenic reporter assays indicated that both the Apt-binding sites and the E2f1-binding sites in the regulatory region of *cycE* are necessary for the normal level of *cycE* transcription.

*apt*-Mutant cells induced in the salivary gland exhibited abnormal nuclei. The size of nucleus/DNA content was \~6.5 times higher than that of control cells, which resulted in de-compacted chromatin. Our study suggests that the unusual phenotype is due to release from Rbf1-mediated chromatin compaction and de-repression of Rbf1-target genes that occupy many loci throughout the genome ([@bib13]). The nuclear size/DNA content of *e2f1*-mutant cells was also higher than that of control cells. However, the difference was less prominent than that between *apt*-mutant cells and control cells. We surmise the following explanation for it. Within a cell, there might exist a balance between the amounts of the E2f1/Dp complex and those of the Rbf1/E2f2/Dp complex. In *e2f1*-mutant cells, the level of the latter complex would increase in the absence of the former complex. This would compensate the decrease in Rbf1 and E2f2 due to reduced Apt, and would direct toward chromatin compaction.

This study underscores the importance of FSBP, a hitherto not-well-characterized transcription factor. Here we found FSBP- and Apt-mediated up-regulation of Rb and Rbf1, respectively. This raises an intriguing possibility that FSBP (Apt) suppresses tumor metastasis through up-regulation of Rb (Rbf1). Future studies should address the issue experimentally.

Limitation of the Study {#sec3.1}
-----------------------

We demonstrate here Apt-dependent up-regulation of *rbf1*. There exists a single Apt-binding motif at 156 nucleotides upstream of the transcription start site of *rbf1*. ChIP assays showed occupancy of Apt on the motif. Therefore, it is most likely that Apt directly activates *rbf1* transcription through the binding site. However, further functional analyses including disruption of the Apt-binding site are necessary to verify the possibility.
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### Material Availability {#sec3.2.2}
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### Data and Code Availability {#sec3.2.3}

This study did not generate new datasets.

Methods {#sec4}
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All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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